Cargando…
Effect of immunosuppressants on a mouse model of osteogenesis imperfecta type V harboring a heterozygous Ifitm5 c.-14C > T mutation
Osteogenesis imperfecta (OI) type V is an autosomal dominant disorder caused by the c.-14C > T mutation in the interferon-induced transmembrane protein 5 gene (IFITM5), however, its onset mechanism remains unclear. In this study, heterozygous c.-14C > T mutant mice were developed to investigat...
Autores principales: | Hanagata, Nobutaka, Takemura, Taro, Kamimura, Keiko, Koda, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713238/ https://www.ncbi.nlm.nih.gov/pubmed/33273604 http://dx.doi.org/10.1038/s41598-020-78403-1 |
Ejemplares similares
-
The IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V
por: Lazarus, Syndia, et al.
Publicado: (2014) -
Phenotypic Variability of Osteogenesis Imperfecta Type V Caused by an IFITM5 Mutation
por: Shapiro, Jay R, et al.
Publicado: (2013) -
Does the c.-14C>T Mutation in the IFITM5 Gene Provide Identical Phenotypes for Osteogenesis Imperfecta Type V? Data from Russia and a Literature Review
por: Tyurin, Anton, et al.
Publicado: (2022) -
IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients
por: Zhytnik, Lidiia, et al.
Publicado: (2019) -
Effects of the overexpression of IFITM5 and IFITM5 c.-14C>T mutation on human osteosarcoma cells
por: Liu, Bao-Yan, et al.
Publicado: (2017)